microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma - Wikidata - awgldk - TriplyDB

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

http://www.wikidata.org/entity/Q33780259

about

Clinical outcome prediction by microRNAs in human cancer: a systematic review Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas miRNA response to DNA damage Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Prognostic role of microRNA-150 in various carcinomas: a meta-analysis The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies Abiraterone in the treatment of metastatic castration-resistant prostate cancer MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune Epigenetics in Brain Tumors: HDACs Take Center Stage MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6 Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma MicroRNAs in B-cell lymphomas: how a complex biology gets more complex A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis MicroRNA-29a inhibited epididymal epithelial cell proliferation by targeting nuclear autoantigenic sperm protein (NASP)Pigmy MicroRNA: surveillance cops in Therapies kingdom miRNA Regulation of DNA Damage Response miRNAs involved in DNA damage response Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.Tissue-specific expression and regulatory networks of pig microRNAome.Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.Targeting microRNAs in cancer: rationale, strategies and challenges.Recurrent amplification at 7q21.2 Targets CDK6 gene in primary myxofibrosarcomas and identifies CDK6 overexpression as an independent adverse prognosticator.The inhibitory role of Mir-29 in growth of breast cancer cells Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma.MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.MicroRNAs Regulate Key Effector Pathways of Senescence MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Polycomb genes, miRNA, and their deregulation in B-cell malignancies

P2860

Q24289183-BFBF424F-9257-4D66-A006-CF38E59C3595 Q24301269-4612DADA-58FD-4AC2-96B0-405E1E49A946 Q24594312-120EFB82-B6E7-4E18-BF85-90445B8BE5DC Q24633394-1EB1707B-B39F-4BFE-907F-FFD9AA2BEE3B Q26748881-79AB949A-37F3-4163-BA51-A665FF829B91 Q26752827-92EA0C74-0ABF-4518-9B56-26DA20DEB8E9 Q26800055-F57D3F28-F7D5-45B9-AB45-C2A3DCC6B581 Q26851373-14D1F53B-8F15-4B81-A390-D1882C5FBE69 Q26853635-6C330890-A3AC-48ED-8570-01760E59B12B Q27013740-95A605D4-7FD4-4BFF-AF47-9C514D14D858 Q28080964-8C68427B-E301-4D88-9867-939DE6555185 Q28116258-96790604-A4FF-45A6-854F-8F1A0E56E440 Q28118099-097782A3-B51C-4568-9FEA-03159B3F2A55 Q28254647-49537ECF-7FE9-4510-8005-E648AF205A75 Q28296641-547E0CC7-B06D-4C4C-A73C-05134E0CE574 Q28566117-2229B617-99A2-4125-A5F3-3B7A7C63A61F Q28818470-E52020B4-D47E-44C7-ABE7-87D3039ACCB9 Q30225374-C99D6204-D49F-4F14-B7A3-61CAA80F90A5 Q30231021-C341D6E8-A23A-4DA2-A15F-6AEE2C9A99D5 Q30353099-2E49E7F6-FC88-42A7-9FAD-5F0E96272809 Q30407678-61806AF1-1527-461F-8E81-2AF21444BA46 Q30456436-AB08ACE8-17B7-4C5B-A382-81FB95B1A86E Q31155408-500F7AA7-7D52-4643-8603-5552B967AF67 Q33862129-CAF550A4-B312-45A8-B4A0-1048C6E46990 Q33982310-F6CC5B17-8EA3-4F24-82B7-70FA20A400E0 Q34141089-5F659E00-DAB3-4582-9B14-E191FEB4029D Q34220592-73E05B2A-051A-473F-A14D-7468A806A3BE Q34249355-F217E774-2243-446A-B0B6-2196F8097B2F Q34259217-0AD9D08E-7D04-46CA-B306-CBAE5A60F64B Q34268278-C5C87F5E-ED95-4711-932A-D52D5E758F15 Q34283601-4B7D66F9-5602-414C-84DC-B465AE7AE739 Q34568868-3050D86B-7CC7-4805-AAB3-FECE13AB204F Q34719895-C1F66A32-514A-4771-A653-8F422F83824D Q34736639-D0CB9C3E-4C09-4D07-A763-8B1F04E96ACD Q34760829-5B6FD2A3-C80D-4D04-B96A-E9EDA7C0B9FB Q34769735-B3990347-E8AA-4C32-B437-ADB8E12386F4 Q35001155-88E5AB0E-647A-4D38-A23B-1B3BC84605C2 Q35002321-B5EC2C46-F845-4201-BD16-E0724CC1A2D9 Q35039281-154BD750-4C4C-42B6-9556-1ADC56003561 Q35103527-0C311570-FAA3-4F70-8001-E166E49B6028

P2860

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

http://www.wikidata.org/entity/Q33780259

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@ast

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@en

type

label

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@ast

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@en

prefLabel

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@ast

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@en

P1433

Q33780259-1FCA081A-9743-41A1-8DE8-A4FC8CCA962E

P1476

Q33780259-0CAD18BF-25E1-40C3-94ED-B2C6D524BCCE

P2093

Q33780259-2185C66C-CCD3-4195-B13D-FA3EAA8DC5C3

Q33780259-2188CD99-9B7F-4525-9D11-21AEAFB62FDF

Q33780259-28C99B07-5ACB-4E6F-8B1F-45660E327688

Q33780259-52DB54AB-E182-4CD2-92E1-DD11AE5E46FF

Q33780259-5E16586B-97C3-4AE3-AE79-6B41F91B92C3

Q33780259-7809AD42-33D1-455F-87F0-FC27D4524D6B

Q33780259-8460DC1E-B773-48CD-82F6-D86979D55F99

Q33780259-A969CF8E-40AB-4BAC-8CAA-AAAF1A141869

Q33780259-C9838C02-E089-4FE9-BEEC-756B8D38E564

Q33780259-CCADAC45-9E47-43F0-B506-37FB97AC9672

P2860

Q33780259-10014AC8-B9EE-4E35-95B0-29178FF0D7E7

Q33780259-1993F0A9-90E8-400B-B953-29618BC8259B

Q33780259-212282D6-B59D-4FD7-9BDF-9C6FC7EAE80F

Q33780259-2F3CBDD1-B5C9-41A7-B034-D55D76AE37FA

Q33780259-31E5DF84-44CE-4AA3-8704-0F0E3383506D

Q33780259-42256770-AC90-4BA8-A8E1-C2047E7765EB

Q33780259-45A25C57-E224-4907-8714-0AA31815A04F

Q33780259-4B0B984F-A160-41E1-829A-0F3C9BC3076F

Q33780259-4CE9D94F-B814-44A3-AACA-43EB16B2F99F

Q33780259-4E0931FE-E45D-4177-AD98-D565AA3B5617

P304

Q33780259-1B0873FE-E819-4D03-9FC9-E1A659DD029E

P31

Q33780259-2B3B11AD-1255-4B9E-A2AC-192876F07BA6

P356

Q33780259-21AB3DE9-6524-424E-9869-6DF4765D4F7F

P407

Q33780259-7AE2239C-BAC5-4934-9997-A71CD114097D

P433

Q33780259-8730D7E6-049B-48DC-BFB8-21A653108271

P478

Q33780259-15E5B7E0-7BA5-4735-B55C-923135C85E26

P577

Q33780259-FB69E3D9-E5CC-4131-9887-C5718F5FA80D

P5875

Q33780259-AD19E13C-0B32-4262-9CA6-9CBA55C2CB68

P698

Q33780259-34F13E1A-269A-4937-9A36-55B7155E273F

P921

Q33780259-186561A4-7DEC-462B-95BA-12B1906B9CA2

Q33780259-3F73ADA0-8316-45D2-8650-97339590AC62

P932

Q33780259-F2D99023-61B7-4613-84C0-67E20A2F65F2

P356

BLOOD-2009-09-243147

P1433

P1476

microRNA expression profile an ...... g CDK6 in mantle cell lymphoma

@en

P2093

Dorna Rezania

http://www.w3.org/2001/XMLSchema#string

Eduardo Sotomayor

http://www.w3.org/2001/XMLSchema#string

Hua Yang

http://www.w3.org/2001/XMLSchema#string

Jian-Jun Zhao

http://www.w3.org/2001/XMLSchema#string

Jianguo Tao

http://www.w3.org/2001/XMLSchema#string

Jianhong Lin

http://www.w3.org/2001/XMLSchema#string

Jianping Guo

http://www.w3.org/2001/XMLSchema#string

Jin Q Cheng

http://www.w3.org/2001/XMLSchema#string

Lynn C Moscinski

http://www.w3.org/2001/XMLSchema#string

Sophie Dessureault

http://www.w3.org/2001/XMLSchema#string

P2860

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

TarBase: A comprehensive database of experimentally supported animal microRNA targets

miRBase: microRNA sequences, targets and gene nomenclature

A microRNA expression signature of human solid tumors defines cancer gene targets

microRNAs exhibit high frequency genomic alterations in human cancer

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Significance analysis of microarrays applied to the ionizing radiation response

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

mir-29 regulates Mcl-1 protein expression and apoptosis

P304

2630-2639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-09-243147

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41088341

http://www.w3.org/2001/XMLSchema#string

P698

20086245

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

P932

2852365

http://www.w3.org/2001/XMLSchema#string